DETAILED NOTES ON ABBV-744 BRD4 INHIBITOR MECHANISM OF ACTION

Added studies in progress propose that ARV-825 might also be effective in maximizing the reaction to estrogen deprivation (aromatase inhibition), another element of standard of care in ER+ breast cancer.General, our present work highlights the potential utilization of ARV-825 in combination with TAM. Though ABBV-744 could also suppress proliferativ